Truffle Hound Capital LLC purchased a new stake in shares of Kewaunee Scientific Co. (NASDAQ:KEQU - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 10,000 shares of the technology company's stock, valued at approximately $619,000. Truffle Hound Capital LLC owned approximately 0.35% of Kewaunee Scientific at the end of the most recent quarter.
Several other institutional investors have also recently bought and sold shares of KEQU. De Lisle Partners LLP boosted its holdings in Kewaunee Scientific by 36.6% during the 3rd quarter. De Lisle Partners LLP now owns 42,958 shares of the technology company's stock worth $1,446,000 after acquiring an additional 11,511 shares during the last quarter. State Street Corp purchased a new position in Kewaunee Scientific during the third quarter worth about $266,000. Janney Montgomery Scott LLC bought a new stake in Kewaunee Scientific in the 4th quarter worth about $338,000. Minerva Advisors LLC grew its position in Kewaunee Scientific by 4.1% in the 4th quarter. Minerva Advisors LLC now owns 109,493 shares of the technology company's stock worth $6,668,000 after purchasing an additional 4,311 shares in the last quarter. Finally, Barclays PLC purchased a new stake in Kewaunee Scientific in the 3rd quarter valued at about $121,000. Institutional investors and hedge funds own 32.69% of the company's stock.
Analyst Ratings Changes
Separately, StockNews.com downgraded Kewaunee Scientific from a "buy" rating to a "hold" rating in a research report on Friday, March 14th.
Read Our Latest Analysis on Kewaunee Scientific
Kewaunee Scientific Stock Performance
NASDAQ:KEQU traded down $0.60 during trading hours on Wednesday, reaching $40.00. The stock had a trading volume of 43,153 shares, compared to its average volume of 22,734. The stock has a market cap of $114.20 million, a P/E ratio of 6.34 and a beta of 0.71. The stock has a 50 day simple moving average of $56.95 and a 200 day simple moving average of $47.55. The company has a debt-to-equity ratio of 0.45, a quick ratio of 2.13 and a current ratio of 2.64. Kewaunee Scientific Co. has a 12-month low of $30.82 and a 12-month high of $71.33.
Kewaunee Scientific (NASDAQ:KEQU - Get Free Report) last released its quarterly earnings data on Wednesday, March 12th. The technology company reported $1.09 earnings per share for the quarter. The business had revenue of $67.17 million during the quarter. Kewaunee Scientific had a net margin of 9.39% and a return on equity of 25.83%.
Insider Buying and Selling at Kewaunee Scientific
In other Kewaunee Scientific news, CEO Thomas David Hull III sold 2,000 shares of the firm's stock in a transaction dated Thursday, December 26th. The stock was sold at an average price of $63.01, for a total transaction of $126,020.00. Following the sale, the chief executive officer now owns 42,497 shares in the company, valued at $2,677,735.97. This trade represents a 4.49 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Donald T. Gardner III sold 1,257 shares of the business's stock in a transaction that occurred on Friday, January 10th. The stock was sold at an average price of $59.26, for a total value of $74,489.82. Following the completion of the sale, the chief financial officer now owns 21,358 shares of the company's stock, valued at $1,265,675.08. The trade was a 5.56 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 11,308 shares of company stock valued at $657,211 in the last 90 days. Corporate insiders own 14.20% of the company's stock.
Kewaunee Scientific Company Profile
(
Free Report)
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
Further Reading

Before you consider Kewaunee Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kewaunee Scientific wasn't on the list.
While Kewaunee Scientific currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.